|
Market Closed -
Other stock markets
|
After hours 19:00:02 | |||
| 44.36 USD | +0.18% |
|
45.37 | +2.28% |
| 06-15 | Alkermes' Sleep Disorder Drug Receives Orphan Drug Status in US and Europe | MT |
| 06-10 | Alkermes plc Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 10:00 AM |
| Market Cap | 7.39B 6.37B 5.87B 5.5B 10.34B 699B 10.44B 69.34B 27.08B 342B 27.75B 27.16B 1,184B | P/E Ratio 2026 * |
-112x | P/E Ratio 2027 * | 78.8x |
|---|---|---|---|---|---|
| Enterprise Value | 8.35B 7.2B 6.63B 6.22B 11.68B 790B 11.8B 78.35B 30.61B 387B 31.35B 30.69B 1,338B | EV / Sales 2026 * |
4.61x | EV / Sales 2027 * | 4.29x |
| Free-Float |
89.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alkermes plc
| 1 day | +0.18% | ||
| 1 week | +4.50% | ||
| Current month | +5.14% | ||
| 1 month | +18.36% | ||
| 3 months | +59.80% | ||
| 6 months | +57.47% | ||
| Current year | +58.54% |
| 1 week | 43.34 |  | 45.76 |
| 1 month | 36.25 | | 45.76 |
| Current year | 27 | | 45.76 |
| 1 year | 25.16 | | 45.76 |
| 3 years | 22.01 | | 45.76 |
| 5 years | 21.24 | | 45.76 |
| 10 years | 11.98 | | 71.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 64 | 1991-01-31 |
Joshua Reed
DFI | Director of Finance/CFO | 53 | 2025-09-14 |
Craig Hopkinson
CTO | Chief Tech/Sci/R&D Officer | 58 | 2017-05-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Pops
CHM | Chairman | 64 | 2011-08-31 |
Nancy Snyderman
BRD | Director/Board Member | 74 | 2016-05-25 |
Shane Cooke
BRD | Director/Board Member | 63 | 2018-03-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-11 | Sell | Director | -2,000 | 0.0012% | ||
| 06-03 | Sell | Compliance Officer | -2,034 | 0.0012% | ||
| 05-31 | Fiscal year | Chief Technology Officer | 19,000 | 0.0114% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.18% | +4.50% | +48.71% | +38.93% | 7.39B | |
| +0.96% | +1.16% | -12.97% | -12.33% | 43.58B | |
| +4.02% | +7.79% | +294.33% | +536.67% | 34.03B | |
| -1.69% | -2.89% | +13.70% | -17.71% | 29.77B | |
| +1.41% | -0.96% | -0.53% | +33.41% | 29.82B | |
| +1.16% | +9.79% | +14.27% | +22.28% | 25.42B | |
| +2.40% | +8.49% | - | - | 13.87B | |
| +0.03% | +2.10% | +56.75% | +111.91% | 13.35B | |
| -1.09% | -2.31% | +5.07% | +5.00% | 12.85B | |
| +0.93% | +0.57% | +107.81% | +77.40% | 12.22B | |
| Average | +0.83% | +2.14% | +58.57% | +88.40% | 22.23B | |
| Weighted average by Cap. | +1.04% | +1.94% | +60.96% | +103.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.81B 1.56B 1.44B 1.35B 2.53B 171B 2.56B 16.99B 6.63B 83.83B 6.8B 6.65B 290B | 1.89B 1.63B 1.5B 1.4B 2.64B 178B 2.67B 17.7B 6.92B 87.37B 7.08B 6.93B 302B |
| Net income | -65.12M -56.13M -51.65M -48.46M -91.03M -6.15B -91.94M -611M -239M -3.01B -244M -239M -10.43B | 103M 88.54M 81.49M 76.44M 144M 9.71B 145M 963M 376M 4.75B 385M 377M 16.45B |
| Net Debt | 961M 828M 763M 715M 1.34B 90.85B 1.36B 9.01B 3.52B 44.49B 3.61B 3.53B 154B | 702M 605M 556M 522M 981M 66.3B 990M 6.58B 2.57B 32.47B 2.63B 2.58B 112B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 44.36 $ | +0.18% | 1,822,144 |
| 26-06-12 | 44.28 $ | -1.42% | 1,523,226 |
| 26-06-11 | 44.92 $ | +2.46% | 2,261,189 |
| 26-06-10 | 43.84 $ | -1.02% | 1,659,661 |
| 26-06-09 | 44.29 $ | +4.33% | 2,533,281 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKS Stock
Select your edition
All financial news and data tailored to specific country editions
